2559
Physicians should therefore be aware of its occurrence and carefully monitor serum levels of CPK, GOT and GPT during the treatment of diabetes insipidus with clofibrate, especially in patients with associated hypothyroidism, latent or overt, which possibly favors the development of myopathy.
 patients with associated hypothyroidism, latent or overt: Subject; hypothyroidism: Subject.Disorder; latent: Subject.Disorder; overt: Subject.Disorder; myopathy.: Effect; clofibrate: Treatment; diabetes insipidus: Treatment.Disorder; clofibrate: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with associated hypothyroidism, latent or overt: Subject; hypothyroidism: Subject.Disorder; latent: Subject.Disorder; overt: Subject.Disorder; myopathy.: Effect; clofibrate: Treatment; diabetes insipidus: Treatment.Disorder; clofibrate: Treatment.Drug